New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol)

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 21, Issue 3

Abstract

Background: Amanita phalloides (Amanita) contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. Patients treated with Amanita often gain a stable disease state without further tumor growth. Aim: Several therapies for prostate cancer are in use so far. This study evaluates the implementation of the Amanita therapy into the therapeutic regimen of today. Methods: 38 Patients with diagnosed prostate cancer were treated with Amanita alone. Prostate specific antigen (PSA) was used as a parameter for tumor cell growth. Data about previous therapies like anti androgen treatment, prostatectomy, chemotherapy or radiation and progression state of the disease were collected, and relationships analyzed. Results: Some patients could be stabilized with Amanita, evidenced by previously increasing PSA that did not increase for at least six months during Amanita therapy. In some patients PSA levels further increased despite Amanita therapy indicating immediate therapy resistance. Analyses revealed that successful Amanita therapy is strongly associated with beginning therapy early, while progressive disease states are often resistant to Amanita (p-value 0,005). Correlation between tumor specific pre-treatments and Amanita therapy resistance is significant: all patients without pre-treatment could be stabilized with Amanita (p-value 0,007). Conclusions: Amanita therapy can reduce tumor growth best in patients without previous treatments, and was most effective in patients without tumor progression. Therefore Amanita should be used first as a tumor specific therapy. Anti androgen treatment, chemotherapy, radiation or prostatectomy can be applied at later stages.

Authors and Affiliations

Isolde Riede

Keywords

Related Articles

Efficacy of Articaine in the Mandibular Infiltration Technique: A Systematic Review

The use of local anesthetic has become more common in dental offices. Throughout the last few years, an anesthetic base of surprising proprieties has been studied with the aim of evaluating the possibility of providing m...

A Prospective Drug Utilization Study in Geriatric Hypertensive Patients in a Tertiary Care Hospital, Mumbai

Introduction: The geriatric population assumes great significance in terms of both preventive and curative health care services utilized. The patho-physio-psychological changes associated with ageing make their problems...

Tolerability of The Copper- T Intrauterine Device by Acceptors at Jos University Teaching Hospital, Jos, North-Central Nigeria

Background: The Copper-T (Cu-T) Intrauterine device (IUD) is one of the oldest and most reliable forms of contraception. Its widespread use has been limited by side effects, such as heavy menstrual flow and pain on inser...

Antibiotic Residues in Meat and Eggs in Taiwan: A Local Surveillance

Aims: To estimate the prevalence and identify risk factors of antibiotic residues in meats and eggs in Taiwan through a cross-sectional study. Methodology: From 1 Jan 2013 to 31 Dec 2014, we collected 175 samples from su...

Neuropathic Pain in Patients with Sciatica: Prevalence and Related Factors

Aim: To assess the prevalence of neuropathic pain (NP) in patients with sciatica and to determine the associated factors with increased incidence of neuropathic component in sciatica. Methods: A cross-sectional study enr...

Download PDF file
  • EP ID EP311867
  • DOI 10.9734/BJMMR/2017/32673
  • Views 65
  • Downloads 0

How To Cite

Isolde Riede (2017). New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol). Journal of Advances in Medicine and Medical Research, 21(3), 1-7. https://europub.co.uk./articles/-A-311867